Fouad Namouni
CIK 1815851 · PRESIDENT, R & D · last filed 2025-07-21
Fouad Namouni is a PRESIDENT, R & D who has filed 20 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for BPMC, was dated Jul 21, 2025. Across all open-market trades the lifetime net is −$2.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.2K
3
20
-$2.18M
Holdings By Company
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-21 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | −75,781 | $0 | EDGAR |
| 2025-05-23 | VOR | Grant (A) | — | $0 | EDGAR |
| 2025-03-07 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −6,489 | -$576.2K | EDGAR |
| 2025-03-04 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | +13,200 | $0 | EDGAR |
| 2024-10-04 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −3,633 | -$324.5K | EDGAR |
| 2024-05-28 | VOR | Grant (A) | — | $0 | EDGAR |
| 2024-05-02 | VOR | Grant (A) | — | $0 | EDGAR |
| 2024-03-11 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −4,377 | -$397.0K | EDGAR |
| 2024-03-06 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
| 2023-10-05 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −3,769 | -$181.1K | EDGAR |